Skelton Laurence Matthew, Chief Commercial Officer at Vera Therapeutics ($VERA), made one open market sale of company shares in the last year, totaling about $66,400 on February 23, 2026. His sales rank 10,073rd among 11,678 insiders, well below the average of $8.6 million per person and 6.4 transactions. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | Vera Therapeutics, Inc. | $VERA | Skelton Laurence Matthew | Chief Commercial Officer | S | Class A Common Stock | 1582 | $41.98 | 64,218.0000 | 63,928,066 | 2.40% | 0.00% |
| Feb. 4, 2026 | Vera Therapeutics, Inc. | $VERA | Skelton Laurence Matthew | Chief Commercial Officer | A | Class A Common Stock | 20000 | $0.00 | 65,800.0000 | 63,928,066 | 43.67% | 0.03% |
| Feb. 4, 2026 | Vera Therapeutics, Inc. | $VERA | Skelton Laurence Matthew | Chief Commercial Officer | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 63,928,066 | 9999.99% | 0.06% |